New Research Study Provides Further Evidence of Strong Correlation of TriPath Imaging's ProEx C Biomarkers with Biopsy Evidence
2005年11月8日 - 1:46AM
PRニュース・ワイアー (英語)
In-house and External Retrospective Research Studies Incorporating
ProEx C Biomarkers Presented at 53rd Annual Scientific Meeting of
the American Society of Cytopathology BURLINGTON, N.C., Nov. 7
/PRNewswire-FirstCall/ -- TriPath Imaging, Inc. (NASDAQ:TPTH) today
announced that the results of a new in-house retrospective research
study demonstrated that testing of cervical cytology specimens with
Research Use Only (RUO) reagents incorporating the Company's
proprietary ProEx C biomarkers yielded a 93% (p
Tripath Imaging (NASDAQ:TPTH)
過去 株価チャート
から 4 2024 まで 5 2024
Tripath Imaging (NASDAQ:TPTH)
過去 株価チャート
から 5 2023 まで 5 2024
Real-Time news about Tripath Imaging (ナスダック市場): 0 recent articles
その他のTripath Imaging Inc. (MM)ニュース記事